American Well Corp R&D Expense

Quick Answer

American Well Corp reported R&D Expense of $72.86 million for fiscal year 2025.

American Well Corp R&D Expense — Annual History

Fiscal Year R&D Expense YoY Change
2025 $72.86M -15.3%
2024 $86.06M -18.7%
2023 $105.83M -23.6%
2022 $138.49M +29.9%
2021 $106.59M +26.3%
2020 $84.41M +56.5%
2019 $53.94M +48.7%
2018 $36.27M

Quarterly R&D Expense

Quarter Ending R&D Expense YoY QoQ
September 30, 2025 $18.58M -6.1% +1.9%
June 30, 2025 $18.24M -12.3% -17.5%
March 31, 2025 $22.10M -17.2% +11.6%
September 30, 2024 $19.80M -28.6% -4.8%
June 30, 2024 $20.81M -19.5% -22.0%
March 31, 2024 $26.68M +2.9% -3.7%
September 30, 2023 $27.71M -23.6% +7.2%
June 30, 2023 $25.84M -30.3% -0.3%
  • American Well Corp showed a decrease of -15.3% in R&D Expense compared to the prior fiscal year.
  • Over the 2018–2025 period, American Well Corp’s r&d expense has grown by 100.9% (from $36.27 million to $72.86 million).
  • The most recent figure is from American Well Corp’s fiscal year 2025 report (Form 10-K), filed with the SEC on February 12, 2026.
  • All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.

Last verified:

Leave a Comment